AdaptHealth/$AHCO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About AdaptHealth
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
Ticker
$AHCO
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
10,500
ISIN
US00653Q1022
Website
AdaptHealth Metrics
BasicAdvanced
$1.1B
14.67
$0.58
1.64
-
Price and volume
Market cap
$1.1B
Beta
1.64
52-week high
$11.90
52-week low
$7.11
Average daily volume
1.1M
Financial strength
Current ratio
1.292
Quick ratio
0.822
Long term debt to equity
129.769
Total debt to equity
133.638
Interest coverage (TTM)
2.23%
Profitability
EBITDA (TTM)
640.222
Gross margin (TTM)
21.99%
Net profit margin (TTM)
2.63%
Operating margin (TTM)
8.52%
Effective tax rate (TTM)
28.32%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
3.82%
Return on equity (TTM)
5.90%
Valuation
Price to earnings (TTM)
14.674
Price to revenue (TTM)
0.351
Price to book
0.71
Price to tangible book (TTM)
-0.96
Price to free cash flow (TTM)
4.145
Free cash flow yield (TTM)
24.12%
Free cash flow per share (TTM)
204.57%
Growth
Revenue change (TTM)
-0.05%
Earnings per share change (TTM)
-110.91%
3-year revenue growth (CAGR)
6.48%
3-year earnings per share growth (CAGR)
-9.81%
What the Analysts think about AdaptHealth
Analyst ratings (Buy, Hold, Sell) for AdaptHealth stock.
Bulls say / Bears say
AdaptHealth's recent refinancing of its senior secured credit facility has extended maturity to September 2029 and reduced the cost of debt, potentially improving financial stability and profitability. (stocktitan.net)
Analysts from Canaccord Genuity Group and Truist Financial have raised their price targets for AdaptHealth to $14.00, maintaining a 'buy' rating, indicating confidence in the company's growth prospects. (techdows.com)
AdaptHealth reported a 6.3% year-over-year increase in net revenue for Q3 2024, driven by strong performance in sleep products, suggesting robust demand in key segments. (benzinga.com)
AdaptHealth's Q3 2024 net income fell short of analyst expectations, leading to a stock price decline of approximately 9.56%. (gurufocus.com)
The company adjusted its full-year revenue guidance downward to a range of $3.22 billion to $3.26 billion, below previous estimates, indicating potential challenges in meeting growth targets. (gurufocus.com)
Insider selling activity, including the COO selling 25,000 shares, may signal concerns about the company's future performance among top executives. (techdows.com)
Data summarised monthly by Lightyear AI. Last updated on 4 Jun 2025.
AdaptHealth Financial Performance
Revenues and expenses
AdaptHealth Earnings Performance
Company profitability
AdaptHealth News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for AdaptHealth stock?
AdaptHealth (AHCO) has a market cap of $1.1B as of June 21, 2025.
What is the P/E ratio for AdaptHealth stock?
The price to earnings (P/E) ratio for AdaptHealth (AHCO) stock is 14.67 as of June 21, 2025.
Does AdaptHealth stock pay dividends?
No, AdaptHealth (AHCO) stock does not pay dividends to its shareholders as of June 21, 2025.
When is the next AdaptHealth dividend payment date?
AdaptHealth (AHCO) stock does not pay dividends to its shareholders.
What is the beta indicator for AdaptHealth?
AdaptHealth (AHCO) has a beta rating of 1.64. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.